• Subscribe
  • Advertise
  • Contact Us
June 16, 2025
Pharma News HQ


  • Home
  • News
  • Clinical Trials
  • Drug Development
  • Manufacturing
  • Packaging and Labeling
  • Cold Chain
  • Diseases
  • Technology
  • Press Feed
    • Articles
    • Press Releases
  • Events
Top Headlines
  • [ February 14, 2023 ] Sun Pharma recalls over 34k bottles of generic drug in US due to manufacturing issues Manufacturing
  • [ February 14, 2023 ] Genenta Science signs manufacturing deal with AGC Biologics Manufacturing
  • [ February 14, 2023 ] Vial and Egnyte announce partnership for eTMF solution integration Clinical Trials
  • [ February 14, 2023 ] SOPHiA GENETICS and AstraZeneca partner for oncology drugs development Drug Development
  • [ February 14, 2023 ] FDA suggests ways to curb constraints with rare disease gene therapy trials Clinical Trials
Home2017

Year: 2017

Press Feed

PureTech’s Akili Achieves Primary Endpoint in Pivotal Study of Investigational Digital Medicine for Paediatric ADHD

October 9, 2017 Pharma News HQ 0

In a randomised, controlled trial of 348 children and adolescents diagnosed with ADHD, AKL-T01 showed a statistically significant improvement compared to an active control (p=0.006) on the predefined primary endpoint, a change in the Attention […]

Articles

New centre is tackling manufacturing challenge of cell therapy field

October 8, 2017 Pharma News HQ 0

Today, the Alliance for Regenerative Medicine estimates there are more than 775 companies working in regenerative medicine or advanced therapies developing products that include cell-based therapies, biologics, tissue-engineered cells, biomaterials and implantable devices, to name […]

Cold Chain

ChillTech® units offer reusability and flexible, modular components

September 3, 2017 Pharma News HQ 0

ChillTech® is a pre-qualified range of 2°C to 8°C PCM systems providing exceptional temperature control from 2 days up to 6 days for payloads from 4L to 40L. ChillTech® utilizes Sonoco ThermoSafe’s patented Zero Bench-Time® […]

News

Boehringer partners with UK’s Autifony for CNS therapeutics

January 21, 2017 Pharma News HQ 0

UK-based biotechnology firm Autifony Therapeutics has entered an agreement with Boehringer Ingelheim regarding select aspects of its Kv3.1/3.2 voltage-gated potassium channel modulator platform. In line with Boehringer’s drug discovery strategy for neuropsychiatric diseases, the collaboration […]

Posts pagination

« 1 … 17 18



















  • Sun Pharma recalls over 34k bottles of generic drug in US due to manufacturing issues

    February 14, 2023 0
  • Genenta Science signs manufacturing deal with AGC Biologics

    February 14, 2023 0
  • Vial and Egnyte announce partnership for eTMF solution integration

    February 14, 2023 0
  • SOPHiA GENETICS and AstraZeneca partner for oncology drugs development

    February 14, 2023 0
  • FDA suggests ways to curb constraints with rare disease gene therapy trials

    February 14, 2023 0
Pharma News HQ

Pharma News HQ, the journal dedicated to the pharmaceutical and biopharmaceutical contract services. With regular sections on contract manufacturing, contract research, contract packaging, formulation/development services, contract analytical testing, APIs, stability testing, clinical research and other areas, we bring the most complete coverage of trends and issues in the industry. Pharmanewshq.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production.

 

About Us

 

Subscribe

 

Contact US

Latest Post
  • Sun Pharma recalls over 34k bottles of generic drug in US due to manufacturing issues

    February 14, 2023 0
  • Genenta Science signs manufacturing deal with AGC Biologics

    February 14, 2023 0
  • Vial and Egnyte announce partnership for eTMF solution integration

    February 14, 2023 0
  • SOPHiA GENETICS and AstraZeneca partner for oncology drugs development

    February 14, 2023 0
  • FDA suggests ways to curb constraints with rare disease gene therapy trials

    February 14, 2023 0